These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6336141)
1. [Trials of immunotherapy in tumors of the urinary tract]. Corrado F; Pizza G Arch Esp Urol; 1984 Dec; 37 Suppl 2():659-66. PubMed ID: 6336141 [No Abstract] [Full Text] [Related]
2. [Treatment of advanced cancer of the urinary tract with interleukin-2 (IL-2)]. Hara M; Terashima Y; Kanamori S; Senga Y; Kondoh Y; Ohhara M; Tsuboi N; Nishimura T; Akimoto M Hinyokika Kiyo; 1988 Oct; 34(10):1693-6. PubMed ID: 3266712 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for the treatment of superficial and infiltrative bladder carcinoma. Cockett AT; Merguerian PA; di Sant'Agnese PA; Wheeless LL Prog Clin Biol Res; 1989; 303():455-62. PubMed ID: 2675003 [No Abstract] [Full Text] [Related]
4. Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma. Hermann GG APMIS Suppl; 1993; 35():1-26. PubMed ID: 8251200 [No Abstract] [Full Text] [Related]
6. Effect of in vitro produced transfer factor on the immune response of cancer patients. Pizza G; Viza D; Boucheix C; Corrado F Eur J Cancer (1965); 1977 Sep; 13(9):917-23. PubMed ID: 578792 [No Abstract] [Full Text] [Related]
12. Immunotherapeutic approaches for renal cancer. Pizza G; de Vinci C; Viza D Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765 [No Abstract] [Full Text] [Related]
13. In vitro produced human antibodies in the treatment of superficial bladder cancer. Corrado F; Pizza G; Casanova S; De Vinci C; Fini M; Severini G; Menniti D; Corrado G J Exp Pathol; 1987; 3(4):347-58. PubMed ID: 3454800 [No Abstract] [Full Text] [Related]
16. [Cytokine therapy of superficial bladder carcinoma. Mechanisms of action and results of therapy]. Otto T; Kälble T Urologe A; 1994 Nov; 33(6):540-6. PubMed ID: 7817454 [TBL] [Abstract][Full Text] [Related]
17. Systemic treatment for renal cell carcinoma: an overview. Swanson DA Prog Clin Biol Res; 1990; 350():201-25. PubMed ID: 2201044 [No Abstract] [Full Text] [Related]
18. Urothelial cancer producing granulocyte colony-stimulating factor: possible induction of splenomegaly. Kitayama S; Fujii Y; Kihara K Urology; 2004 Feb; 63(2):377-8. PubMed ID: 14972497 [No Abstract] [Full Text] [Related]
19. Induction and analysis of tumor immunity using anti-idiotypic antibodies. Hellström KE; Lee V; Nelson K; Hellström I Monogr Allergy; 1987; 22():212-21. PubMed ID: 3501835 [No Abstract] [Full Text] [Related]
20. Therapeutic requirements for the successful treatment of murine renal carcinoma by adoptive chemoimmunotherapy. Wiltrout RH; Mathieson BJ; Back TC; Salup RR Prog Clin Biol Res; 1987; 244():17-25. PubMed ID: 3498946 [No Abstract] [Full Text] [Related] [Next] [New Search]